The characteristics of TP53 germline mutations analyzed in a large-scale cohort of Chinese glioma patients

被引：0
|
作者：
Hong, Xinyu [1 ]
Zhao, Ximeng [2 ]
Guo, Zeshang [1 ]
Yang, Xiaochen [1 ]
Guo, Bella [2 ]
Zhang, Xiang [2 ]
Ma, Tonghui [2 ]
机构：
[1] Jilin Univ, Bethune Hosp 1, Changchun, Peoples R China
[2] Genetron Hlth Beijing Co Ltd, Beijing, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5840
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Loss of heterozygosity in tumours of carriers of germline TP53 mutations
    Goetz, P
    Trkova, M
    Foretova, L
    Krutilkova, V
    Kodet, R
    Mares, J
    Sedlacek, Z
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 89 - 89
  • [22] Large-scale evaluation of the clinical impact of clonal hematopoiesis in TP53
    Usui, Yoshiaki
    Endo, Mikiko
    Iwasaki, Yusuke
    Iijima, Hanae
    Matsuda, Koichi
    Momozawa, Yukihide
    CANCER SCIENCE, 2025, 116 : 922 - 922
  • [23] High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort
    Mitchell, Gillian
    Ballinger, Mandy L.
    Wong, Stephen
    Hewitt, Chelsee
    James, Paul
    Young, Mary-Anne
    Cipponi, Arcadi
    Pang, Tiffany
    Goode, David L.
    Dobrovic, Alex
    Thomas, David M.
    PLOS ONE, 2013, 8 (07):
  • [24] Prevalence of Germline TP53 Mutations in a Prospective Series of Unselected Patients with Adrenocortical Carcinoma
    Raymond, Victoria M.
    Else, Tobias
    Everett, Jessica N.
    Long, Jessica M.
    Gruber, Stephen B.
    Hammer, Gary D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (01): : E119 - E125
  • [25] Prevalence of germline TP53 mutations in HER2+ breast cancer patients
    Michelle G. Rath
    Serena Masciari
    Rebecca Gelman
    Alexander Miron
    Penelope Miron
    Kathleen Foley
    Andrea L. Richardson
    Ian E. Krop
    Sigitas J. Verselis
    Deborah A. Dillon
    Judy E. Garber
    Breast Cancer Research and Treatment, 2013, 139 : 193 - 198
  • [26] Prevalence of germline TP53 mutations in HER2+breast cancer patients
    Rath, Michelle G.
    Masciari, Serena
    Gelman, Rebecca
    Miron, Alexander
    Miron, Penelope
    Foley, Kathleen
    Richardson, Andrea L.
    Krop, Ian E.
    Verselis, Sigitas J.
    Dillon, Deborah A.
    Garber, Judy E.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (01) : 193 - 198
  • [27] The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
    Finkova, Alena
    Vazna, Alzbeta
    Hrachovina, Ondrej
    Bendova, Sarka
    Prochazkova, Kamila
    Sedlacek, Zdenek
    CANCER GENETICS AND CYTOGENETICS, 2009, 193 (01) : 63 - 66
  • [28] Choroid Plexus Carcinomas With TP53 Germline Mutations: Management and Outcome
    Li, Yanong
    Liu, Hailong
    Li, Tandy
    Feng, Jin
    He, Yanjiao
    Chen, Li
    Li, Chunde
    Qiu, Xiaoguang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma
    Andrade, Raissa C.
    de Lima, Maria A. F. D.
    de Faria, Paulo A. S.
    Vargas, Fernando R.
    FAMILIAL CANCER, 2018, 17 (01) : 119 - 122
  • [30] TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma
    Raissa C. Andrade
    Maria A. F. D. de Lima
    Paulo A. S. de Faria
    Fernando R. Vargas
    Familial Cancer, 2018, 17 : 119 - 122
12345